Filing Details
- Accession Number:
- 0001209191-24-000366
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-03 16:20:10
- Reporting Period:
- 2023-12-29
- Accepted Time:
- 2024-01-03 16:20:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1810182 | Alx Oncology Holdings Inc | ALXO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1188956 | S Peter Garcia | C/O Alx Oncology Holdings Inc. 323 Allerton Avenue South San Francisco CA 94080 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-12-29 | 1,893 | $15.04 | 85,348 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.
- Includes 503 shares acquired under the Issuer's employee stock purchase plan on December 29, 2023.